Name | salicylylsalicylic acid |
Synonyms | Salina diagen Salysal Saloxium salflex salgesic disalcid salsitab salsalate amigesic sasapyrine mono-gesic Salicyl-salicylate salicyloylsalicylicacid salicylylsalicylic acid 2-salicylsalicylic acid Salicyloxysalicylic acid Salicyloylsalicylic acid salicylicacid,bimolecularester 2-[(2-hydroxybenzoyl)oxy]benzoic acid 2-{[(2-hydroxyphenyl)carbonyl]oxy}benzoate 2-hydroxybenzoic acid 2-carboxyphenyl ester |
CAS | 552-94-3 |
EINECS | 209-027-4 |
InChI | InChI=1/C14H10O5/c15-11-7-3-1-5-9(11)14(18)19-12-8-4-2-6-10(12)13(16)17/h1-8,15H,(H,16,17)/p-1 |
Molecular Formula | C14H10O5 |
Molar Mass | 258.23 |
Density | 1.3326 (rough estimate) |
Melting Point | 139-151 °C |
Boling Point | 361.48°C (rough estimate) |
Flash Point | 188°C |
Water Solubility | HYDROLYSIS |
Solubility | Soluble in water (hydrolyzes slowly), DMSO (52 mg/ml at 25 °C), ethanol (52 mg/ml |
Vapor Presure | 3.88E-10mmHg at 25°C |
Appearance | White crystal |
Color | white to tan |
Merck | 14,8339 |
pKa | pKa 3.5 (Uncertain);9.8 (Uncertain) |
Storage Condition | 2-8°C |
Sensitive | Moisture Sensitive |
Refractive Index | 1.4825 (estimate) |
MDL | MFCD00020252 |
Physical and Chemical Properties | Melting point 148-151°C water-soluble hydrogen |
Use | Used as analgesic and anti-inflammatory drugs |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R50 - Very Toxic to aquatic organisms R22 - Harmful if swallowed |
Safety Description | S37/39 - Wear suitable gloves and eye/face protection S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S61 - Avoid release to the environment. Refer to special instructions / safety data sheets. |
UN IDs | UN 3077 9 / PGIII |
WGK Germany | 3 |
RTECS | DH2080000 |
TSCA | Yes |
HS Code | 29182300 |
This product is 2-Hydroxybenzoic acid -2-carboxyl phenyl ester. Calculated as dried product, containing no less than 99.0% of C14H10O5.
The melting point of this product (General 0612) is 140~146°C.
take about 0.5g of this product, add 5ml of sodium hydroxide solution, boil and show the identification reaction of salicylate (General rule 0301).
take 1.0g of this product, add 20ml of water, shake, filter, take 4ml of filtrate, check according to law (General rule 0801), and compare with the control solution made of 1 ml of standard sodium chloride solution, no more concentrated (0.005%).
take 5ml of filtrate under chloride examination, add 1 ml of dilute hydrochloric acid and 3ml of barium chloride test solution, and no turbidity.
take this product l.O g, add chloroform 20ml to dissolve, as a test solution; Take about 25mg of salicylic acid, precision weighing, 100ml flask, add chloroform dissolved and diluted to the scale, shake, 20ml was accurately measured and used as a control solution. Put the above two solutions in the separatory funnel, and extract 4 times with ferric nitrate solution [Take lg of ferric nitrate, dissolve with nitric acid solution (0.1-100), and dilute to 1000ml], 20ml each time, take the ferric nitrate solution, filter, put it in a 100ml measuring flask, dilute it to the scale with ferric nitrate solution, and shake it well. The absorbance was measured at a wavelength of 0401 NM according to UV-Vis spectrophotometry (general rule). The absorbance of the test solution shall not be greater than that of the control solution.
take this product, with phosphorus pentoxide as desiccant, at 60°C under reduced pressure drying to constant weight, weight loss should not exceed 0.5% (General rule 0831).
not more than 0.1% (General rule 0841).
take 5ml of filtrate under chloride check item, add several drops of sodium sulfide test solution, and the solution should not develop color.
take this product about 0.5g, precision weighing, add ethanol 40ml to dissolve, add phenolphthalein indicator solution 0.2 ml, with sodium hydroxide titration solution (0.1 mol/L) titration, and the results of the titration were corrected with a blank test. Each 1 ml of sodium hydroxide titration solution (0.1 mol/L) corresponds to 25.82mg of C14H10O5.
antipyretic analgesic, non-steroidal anti-inflammatory drugs.
light shielding, sealed storage.
This product contains double salicyl ester (C14H1005) should be the label amount of 95.0% ~ 105.0%.
This product is white tablet.
take an appropriate amount of fine powder of this product (about 0.3g of salicylate bihydrate), add 5ml of sodium hydroxide solution, shake to dissolve the salicylate dihydrate, filter, and boil the filtrate, according to the identification test under the double water Yang Ester, the same reaction was shown.
Take 20 tablets of this product, precise weighing, fine grinding, precise weighing appropriate amount (about equivalent to 0.3g of double water Poplar ester), add 40ml of ethanol, shake to dissolve double water Poplar Ester, phenolphthalein indicator solution 0.2, with sodium hydroxide titration solution (0.1 mol/L) titration, and the results of the titration were corrected with a blank test. Each 1 ml of sodium hydroxide titration solution (0.1 mol/L) corresponds to 25.82mg of C14H10O5.
The same as salicylate.
0.3g
light shielding, sealed storage.
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
overview | bissalicylate (salsalate,SAL) is a salicylic acid dimer connected to head and tail, which does not stimulate gastric mucosa and has no inhibitory effect on platelets. Salicylic acid drugs are common non-steroidal anti-inflammatory drugs. They are widely used as antipyretic, analgesic, anti-inflammatory and anti-rheumatic drugs. Their effects on lowering blood sugar and preventing thrombotic diseases have also attracted attention. |
pharmacological effects | bissalicylate is similar to aspirin, and has antipyretic, analgesic and anti-inflammatory effects. |
biological activity | Sasapyrine (Salsalate, NSC-49171) is an oral non-steroidal anti-inflammatory drug. |
use | as an analgesic and anti-inflammatory drug |